カテゴリ： MarketLine, スイス, 企業調査

Valiant Holding AG：企業の戦略・SWOT・財務分析

◆英語タイトル：Valiant Holding AG - Strategy, SWOT and Corporate Finance Report
◆商品コード：SWOT20MY3720
◆発行会社（調査会社）：MarketLine
◆発行日：2019年12月
◆ページ数：30
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：スイス
◆産業分野：Financial Services
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Valiant Holding AG – Strategy, SWOT and Corporate Finance Report
Summary

Valiant Holding AG – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Valiant Holding AG (Valiant Holding) is a financial holding company that offers a range of retail, and private banking; and other financial solutions to private clients and SMEs through its subsidiary, Valiant Bank. It offers mortgages, loans, savings accounts, deposits, credit cards, debit cards, and investment solutions. The company also offers services such as real estate financing, bank guarantees, medium term notes, bonds, pension funds, leasing, financial planning, payment services, asset management, Internet banking, phone banking, and ATM. It serves individuals, high net worth individuals, and SMEs in Switzerland. Valiant Holding is headquartered in Luzern, Switzerland.

Scope

- Detailed information on Valiant Holding AG required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Valiant Holding AG in the form of a SWOT analysis
- An in-depth view of the business model of Valiant Holding AG including a breakdown and examination of key business segments
- Intelligence on Valiant Holding AG’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Valiant Holding AG, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Valiant Holding AG and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Valiant Holding AG as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Valiant Holding AG’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Valiant Holding AG: Company Overview
Valiant Holding AG: Overview and Key Facts
Valiant Holding AG: Overview
Valiant Holding AG: Key Facts
Valiant Holding AG: Key Employees
Valiant Holding AG: Key Employee Biographies
Valiant Holding AG: Major Products and Services
Valiant Holding AG: Company History
Valiant Holding AG: Management Statement
Valiant Holding AG: Locations and Subsidiaries
Valiant Holding AG: Key Competitors
Valiant Holding AG: Company Analysis
Valiant Holding AG: Business Description
Valiant Holding AG: SWOT Analysis
Valiant Holding AG: SWOT Overview
Valiant Holding AG: Strengths
Valiant Holding AG: Weaknesses
Valiant Holding AG: Opportunities
Valiant Holding AG: Threats
Valiant Holding AG: Corporate Financial Deals Activity
Valiant Holding AG: Financial Deals Overview
Valiant Holding AG: Top Deals 2015 – 2019YTD*
Valiant Holding AG: Capital Raising
Valiant Holding AG: Recent Developments
Valiant Holding AG: News and Events Summary
Valiant Holding AG: Financial Deals
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Valiant Holding AG: Key Facts
Table 2: Valiant Holding AG: Key Employees
Table 3: Valiant Holding AG: Company History
Table 4: Valiant Holding AG: Locations and Subsidiaries
Table 5: Valiant Holding AG: Key Competitors
Table 6: Valiant Holding AG: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Valiant Holding AG: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Valiant Holding AG: Top Deals 2015 - 2019YTD*
Table 9: Valiant Holding AG: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 10: Valiant Holding AG: Capital Raising by Deal Type (2015 - YTD*2019)
Table 11: Valiant Holding AG: News and Events Summary
Table 12: Valiant Holding AG: Financial Deals

★海外企業調査レポート[Valiant Holding AG：企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • OctreoPharm Sciences GmbH-医療機器分野：企業M&A・提携分析
    Summary OctreoPharm Sciences GmbH (OPS), a subsidiary of Ipsen SA is a clinical development biopharmaceutical company that develops radiopharmaceuticals for the diagnosis and therapeutic control of tumors. The company develops theranostic couple of antagonistic peptides for the diagnosis and treatme …
  • TiGenix NV (TIG)：企業の財務・戦略的SWOT分析
    Summary TiGenix NV (TiGenix), a subsidiary of Takeda Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and commercializes novel therapeutic products. The company exploits the anti-inflammatory properties of stem cells to develop novel therapies. It offers products such as AlloCSC-0 …
  • Atossa Genetics Inc：企業のM&A・事業提携・投資動向
    Atossa Genetics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atossa Genetics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Grupo Argos SA：企業の戦略・SWOT・財務分析
    Grupo Argos SA - Strategy, SWOT and Corporate Finance Report Summary Grupo Argos SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Seven Bank, Ltd.：企業の戦略・SWOT・財務情報
    Seven Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Seven Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • China CITIC Bank International Limited：企業の戦略・SWOT・財務情報
    China CITIC Bank International Limited - Strategy, SWOT and Corporate Finance Report Summary China CITIC Bank International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Mississippi Power Co：企業の戦略的SWOT分析
    Mississippi Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • GlycoMimetics Inc (GLYC)：製薬・医療：M&Aディール及び事業提携情報
    Summary GlycoMimetics Inc (GlycoMimetics) is a clinical-stage biotechnology company that research, develops and commercializes small molecule drugs. The company’s products comprise rivipansel (GMI-1070), under phase III clinical trial is an anti-inflammatory compound to treat vaso-occlusive crisis o …
  • Brainsway Ltd (BRIN)：企業の財務・戦略的SWOT分析
    Summary Brainsway Ltd (Brainsway) is a medical device company that develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of neurological and psychopathological disorders. The company provides deep transcranial magnetic stimulation products. It of …
  • Cancer Research Technology Ltd：医療機器：M&Aディール及び事業提携情報
    Summary Cancer Research Technology Ltd (CRT), formerly Cancer Research Campaign Technology Ltd, a subsidiary of Cancer Research UK, is a research organization that develops and commercializes discoveries for treatment in the areas of cancer. The organization offers services such as project developme …
  • BM-Bank Public Joint Stock Company：企業のM&A・事業提携・投資動向
    BM-Bank Public Joint Stock Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BM-Bank Public Joint Stock Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Michigan Public Power Agency：企業の戦略的SWOT分析
    Michigan Public Power Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Federal Signal Corporation：企業の戦略・SWOT・財務分析
    Federal Signal Corporation - Strategy, SWOT and Corporate Finance Report Summary Federal Signal Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • RiceBran Technologies (RIBT)：企業の財務・戦略的SWOT分析
    RiceBran Technologies (RIBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Opthea Ltd (OPT)：医療機器：M&Aディール及び事業提携情報
    Summary Opthea Ltd (Opthea), formerly Circadian Technologies Ltd, is a biotechnology company that develops novel biologic therapy for the treatment of eye diseases. The company carries out research and development of angiogenesis and vascular leakage-based treatments for cancer concentrating on vasc …
  • InVivo Therapeutics Corp：企業の製品パイプライン分析2018
    Summary InVivo Therapeutics Corp (InVivo), a subsidiary of InVivo Therapeutics Holdings Corp, is a medical device company that offers therapeutic products. The company develops and commercializes groundbreaking treatments for spinal cord injuries. Its products include biocompatible neuro spinal scaf …
  • Central Rand Gold Ltd：企業の戦略・SWOT・財務情報
    Central Rand Gold Ltd - Strategy, SWOT and Corporate Finance Report Summary Central Rand Gold Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Moody’s Corporation：企業の戦略・SWOT・財務情報
    Moody's Corporation - Strategy, SWOT and Corporate Finance Report Summary Moody's Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Autotelic Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Autotelic Inc (Autotelic) is a therapeutic drug monitoring company that develops novel treatments using its therapeutic drug monitoring (TDM) services. The company's pipeline products include devices to improve safety and efficacy of COX-2 inhibitors, paclitaxel nanomedicine, TGF-beta inhibi …
  • Nattopharma ASA (NATTO)：企業の財務・戦略的SWOT分析
    Summary Nattopharma ASA (Nattopharma) is a pharmaceutical company that develops and sells vitamin K2 for health care industries. The company's MenaQ7, a vitamin K2 as menaquinone-7 for bone and cardiovascular health and children’s health. Its MenaQ7 varieties are suitable for vegans and vegetarians, …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆